Literature DB >> 11414346

Prospective matching of alcoholic clients to cognitive-behavioral or interactional group therapy.

R M Kadden1, M D Litt, N L Cooney, E Kabela, H Getter.   

Abstract

OBJECTIVE: In earlier work, client sociopathy and global psychopathology were effective variables for treatment matching: clients low on both sociopathy and severity of psychopathology were likely to benefit from interactional group therapy, whereas those scoring high on either of these dimensions benefited more from a coping skills intervention. The present study assessed whether outcomes improve further when clients are assigned to group treatments prospectively based on a matching strategy derived from the previous findings.
METHOD: All participants (N = 250, 66% men) met criteria for alcohol dependence or abuse. About half were prospectively assigned to either cognitive-behavioral (CB) coping skills training or interactional therapy, those with higher levels of psychiatric severity or sociopathy were given CB and those who were low on both dimensions were given interactional therapy. The other half were randomly assigned to those treatments, replicating the procedure of the earlier study. Outcome data were collected at the conclusion of treatment and at 3-month intervals for 1 year following.
RESULTS: Prospective matching of clients to treatment did not produce superior drinking outcomes compared to random treatment assignment. Randomly assigned clients were more likely to be abstinent at the end of treatment, but this effect disappeared at later follow-ups. Prospectively matched clients had fewer negative consequences of drinking than did those assigned randomly (unmatched). Neither sociopathy nor psychiatric severity was particularly effective for matching.
CONCLUSIONS: The matching effects from our previous study were not replicated. Nevertheless, prospective matching did reduce the negative consequences of drinking, consistent with our previous results.

Entities:  

Mesh:

Year:  2001        PMID: 11414346     DOI: 10.15288/jsa.2001.62.359

Source DB:  PubMed          Journal:  J Stud Alcohol        ISSN: 0096-882X


  8 in total

Review 1.  Cognitive enhancement as a treatment for drug addictions.

Authors:  Mehmet Sofuoglu; Elise E DeVito; Andrew J Waters; Kathleen M Carroll
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

2.  Treatment response and non-response in CBT and Network Support for alcohol disorders: targeted mechanisms and common factors.

Authors:  Mark D Litt; Ronald M Kadden; Howard Tennen
Journal:  Addiction       Date:  2018-04-20       Impact factor: 6.526

3.  An IRT-based measure of alcohol trait severity and the role of traitedness in trait validity: a reanalysis of Project MATCH data.

Authors:  Leslie C Morey; Christopher J Hopwood
Journal:  Drug Alcohol Depend       Date:  2009-08-07       Impact factor: 4.492

4.  ANALYSIS OF ROLLING GROUP THERAPY DATA USING CONDITIONALLY AUTOREGRESSIVE PRIORS.

Authors:  Susan M Paddock; Sarah B Hunter; Katherine E Watkins; Daniel F McCaffrey
Journal:  Ann Appl Stat       Date:  2011-06       Impact factor: 2.083

5.  Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials.

Authors:  Molly Magill; Lara A Ray
Journal:  J Stud Alcohol Drugs       Date:  2009-07       Impact factor: 2.582

6.  Individualized assessment and treatment program for alcohol dependence: results of an initial study to train coping skills.

Authors:  Mark D Litt; Ronald M Kadden; Elise Kabela-Cormier
Journal:  Addiction       Date:  2009-08-27       Impact factor: 6.526

7.  Millon Clinical Multiaxial Inventory-III subtypes of opioid dependence: validity and matching to behavioral therapies.

Authors:  Samuel A Ball; Charla Nich; Bruce J Rounsaville; Dorothy Eagan; Kathleen M Carroll
Journal:  J Consult Clin Psychol       Date:  2004-08

8.  Task-shifting alcohol interventions for HIV+ persons in Kenya: a cost-benefit analysis.

Authors:  Omar Galárraga; Burke Gao; Benson N Gakinya; Debra A Klein; Richard G Wamai; John E Sidle; Rebecca K Papas
Journal:  BMC Health Serv Res       Date:  2017-03-28       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.